Article

Lessons from the BEAT Trial: Implications for Inhaled Treprostinil

2026-06-09

Abstract excerpt

<title>Abstract</title> <p>Background Combination therapy is recommended for pulmonary arterial hypertension (PAH), part of which generally includes prostanoids, which affect both the vascular tone and vessel remodeling seen in PAH. This study tested whether a dual prostacyclin treatment strategy (oral esuberaprost + inhaled treprostinil and oral background PAH therapies) would provide additional clinical benefi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4feed1a3-883a-5ed8-b8c6-5e6c8d1ff0c2
DOI: 10.21203/rs.3.rs-9556444/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Lessons from the BEAT Trial: Implications for Inhaled TreprostinilDOI 10.21203/rs.3.rs-9556444/v1Read

Idiopathic pulmonary arterial hypertension.Semantic proximity Read

Idiopathic pulmonary arterial hypertension: current state of play and new treatment modalities.Semantic proximity Read

Management of Pulmonary Arterial Hypertension. Current Strategies and Future ProspectsSemantic proximity Read

Treprostinil in the treatment of pediatric patients with severe Idiopathic and Heritable Pulmonary Arterial HypertensionSemantic proximity Read

Recent Advances in the Treatment of Pulmonary Arterial Hypertension Associated with Connective Tissue DiseasesSemantic proximity Read

Pulmonary Hypertension: Pharmacological and Non-Pharmacological TherapiesSemantic proximity Read

Rapid Inpatient Uptitration of Inhaled Treprostinil in PH-ILD Patients with Severe Phenotype.Semantic proximity Read

Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.Semantic proximity Read

Clinical and Hemodynamic Characterization Super Responders to IV Prostacyclin in Pulmonary Arterial HypertensionSemantic proximity Read

Off Label Use of Tenecteplase in the Management of High-Risk Pulmonary EmbolismSemantic proximity Read

Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.Semantic proximity Read

Toward Precision Medicine in Pulmonary Arterial Hypertension.Semantic proximity Read